San Diego Business Journal

Federal Cutbacks Gut Biomedical Research

By Joseph Panetta Friday, October 31, 2014

Imagine this scenario: After receiving government research funding for many years, a small biotech company achieves the near impossible — approval from regulators of a safe and effective drug that reverses the effects of Alzheimer’s disease...


Page 1 of 2.

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

  • 51 weekly issues: $153 value
  • Subscriber-only digital content every business day, plus full access to archives: $150 value
  • Book of Lists — the biggest, hottest companies in San Diego: $75 value
  • NEW: San Diego 500 — influential business leaders you need to know: $50 value
  • Total Package Value: $428

Yours for only $129